FMTX - Forma Therapeutics Holdings - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Forma Therapeutics Holdings's activity chart (see below) currently has 25 price targets and 22 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 15.38% with an average time for these price targets to be met of 18.92 days.

Most recent stock forecast was given by MARK BREIDENBACH from OPPENHEIMER on 02-Sep-2022. First documented stock forecast 14-Jul-2020.

Best performing analysts who are covering FMTX - Forma Therapeutics Holdings:

Andrew Berens Emma Nealon Mark Breidenbach Maury Raycroft Tiago Fauth Robert Burns Prakhar Agrawal

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 17-Feb-2021

$49

4 years 29 days ago
(02-Sep-2022)

0/3 (0%)

$39.17 (398.47%)

Buy Since 15-Jun-2021

$20

$-0.01 (-0.05%)

$40

4 years 29 days ago
(02-Sep-2022)

1/2 (50%)

$0.02 (0.10%)

41

Buy Since 14-Jul-2020

$20

$-0.01 (-0.05%)

$62

4 years 29 days ago
(02-Sep-2022)

1/4 (25%)

$0.02 (0.10%)

41

Buy Since 08-Sep-2020

$20

$-0.01 (-0.05%)

$53

4 years 29 days ago
(02-Sep-2022)

1/4 (25%)

$0.02 (0.10%)

41

Buy Since 13-Jun-2022

$21

$0.99 (4.95%)

4 years 3 months 18 days ago
(13-Jun-2022)

0/1 (0%)

$15.82 (305.41%)

Show more analysts

Please expand the browser size to see the chart

What is FMTX (Forma Therapeutics Holdings) average time for price targets to be met?

On average it took 19 days for the stock forecasts to be reached, with an average price target met ratio of 15.38%.

Which analyst most recently updated their price target on FMTX (Forma Therapeutics Holdings)?

Mark Breidenbach

Which analyst has the most public recommendations on FMTX (Forma Therapeutics Holdings)?

Mark Breidenbach has 22 price targets and 17 ratings on FMTX

Which analyst is the currently most bullish on FMTX (Forma Therapeutics Holdings)?

Emma Nealon with the highest potential upside of $47.99

Which analyst is the currently most reserved on FMTX (Forma Therapeutics Holdings)?

Maury Raycroft with the lowest potential downside of -$0.01
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?